Clinical Trial Update: A Study Investigating the Utilization, Effectiveness and Quality of Life in Clinical Practice in Germany for Participants With Relapsing-remitting Multiple Sclerosis Treated With Ozanimod (Zeposia®)

View source ↗

Summary

A completed real-world study in Germany evaluated how ozanimod is used, its effectiveness, and quality of life in participants with relapsing-remitting multiple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Zeposia (ozanimod hydrochloride)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Multiple Sclerosis, Relapsing-Remitting | Status: COMPLETED